Carlsmed, Inc. Common Stock (CARL) Stock Price
CARLStock
$16.88+23.30%52W
Market Cap$460.87M
P/E—
PEG Ratio—
Div yield—
Beta2.21
CARL Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)17.32%
Price vs S&P 500 (4W)29.01%
VGM Score85.55
CARL Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.40 | -$0.39 | +1.27%(+$0.01) | |
| Q1 2026 | -$0.40 | -$0.26 | +33.34%(+$0.13) | |
| Q4 2025 | -$0.43 | -$0.29 | +31.54%(+$0.14) | |
| Q3 2025 | -$0.49 | -$0.37 | +24.51%(+$0.12) | |
| Q2 2025 | -$0.92 | -$1.37 | -49.32%(-$0.45) |
CARL Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.27
4.27
4.27
4.27
Industry Peers — Surgical & Medical Instruments(140)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CARLCarlsmed, Inc. Common Stock | — | A | A | $16.88 |
| SYKStryker Corporation | C | B | C | $330.69 |
| MMM3M Company | C | D | C | $174.34 |
| BSXBoston Scientific Corp. | C | B | D | $46.84 |
| BDXBecton, Dickinson and Co. | B | D | B | $189.52 |
| MDLNMedline Inc. Class A common stock | C | D | C | $35.28 |
| RMDResMed Inc. | C | B | B | $240.33 |
| DXCMDexCom, Inc. | D | B | B | $90.82 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $337.47 |
| SOLVSolventum Corporation | C | C | B | $91.12 |
| BAXBaxter International Inc. | B | D | B | $26.13 |
About Carlsmed, Inc. Common Stock
Carlsmed Inc is a commercial-stage medical technology company developing AI-enabled personalized solutions for spine surgery. Its Aprevo platform delivers customized surgical planning and implants for lumbar and cervical fusion procedures, marketed to hospitals and ambulatory surgical centers.